SEER Inquiry System - Question 20000493 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 11/19/2025 5:43 PM

Question 20000493

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

SEER EOD-88, 3rd Ed, 137

Question:

EOD-Clinical Extension--Prostate: For prostate cancer, can an elevated PSA be used to code metastasis? See discussion.

Discussion:

5/31/98 PE: 30 gm prostate with nodularity, suspicious for CA.

Final diagnosis: Stage D Ca of prostate with mets, NOS

PTA IVP: Normal collecting system

5/11/98 CXR: NED

PSA 86.3 Suggestive of prostate Ca per MD

5/13/98 TURP and bilat. orchiectomy: Plan was to perform orchiectomy as treatment of choice if biopsy was positive. Appears MD feels that the patient has mets, NOS based on the elevated PSA.

5/13/98 TURP Adenocarcinoma, PD

Answer:

For cases diagnosed 1998-2003, do not code the EOD-Clinical Extension field based on elevated PSA alone. If a recognized practitioner states that there is metastasis, then metastasis should be coded.

In this case, code the EOD-Clinical Extension field to 85 [Metastasis] because it is Stage D. But if you had D1 or D2 staging based on the involvement of lymph nodes, then that involvement would be coded under EOD lymph nodes and not under the clinical extension field.

Cancer Site Category:

Prostate

Data Item Category:

N/A

Other Category:

N/A

Year:

2000